| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Grass pollen allergen extract |
| Brand | Oralair® |
| Indication | For the treatment of allergic grass pollen rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms confirmed by a positive cutaneous test and/or a positive titre of the specific IgE to the grass pollen. |
| Assessment Process | |
| Rapid review commissioned | 26/09/2011 |
| Rapid review completed | 03/10/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |
